Ardelyx ARDX
NASDAQ ARDX
$3.34 -0.04 (-1.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ardelyx (ARDX) Return on Sales [ROS] (2013 - 2026)

Updated

Ardelyx (ARDX) posted Return on Sales [ROS] of -10.28% for Q2 2026, up 4.46 percentage points from -14.74% a year earlier and up 24.43 percentage points from the prior quarter.

Analysis

Ardelyx (ARDX) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ardelyx was -7.86%, up 2.60 percentage points year-over-year; for FY2025, it was -10.06%, down 1.68 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +1188.99 percentage points (FY2020 to FY2025).
  • In prior years, Ardelyx's Return on Sales [ROS] was -8.38% in FY2024 (+42.46 pp), -50.84% in FY2023 (+71.40 pp), -122.24% in FY2022 (+1406.39 pp) and -1528.63% in FY2021 (-329.58 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -5941.67% in Q1 2022 to a high of 27.49% in Q4 2022 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +12.98 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2023, with a gain of 5712.41 percentage points; the weakest was Q1 2022, with a drop of 5455.42 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -34.71% (Q1 2026), 4.07% (Q4 2025) and 4.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Ardelyx 832.15 Mn -195.15 Mn 115.12 Mn -10.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.28%
Mar 31, 2026 -34.71%
Dec 31, 2025 4.07%
Sep 30, 2025 4.23%
Jun 30, 2025 -14.74%
Mar 31, 2025 -49.04%
Dec 31, 2024 7.00%
Sep 30, 2024 2.27%
Jun 30, 2024 -18.61%
Mar 31, 2024 -53.62%
Dec 31, 2023 -81.44%
Sep 30, 2023 13.12%
Jun 30, 2023 -74.44%
Mar 31, 2023 -229.25%
Dec 31, 2022 27.49%
Sep 30, 2022 -438.83%
Jun 30, 2022 -1,037.81%
Mar 31, 2022 -5,941.67%
Dec 31, 2021 -3,427.89%
Sep 30, 2021 -3,600.68%
API Access

Ardelyx Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARDX&period=max&api_key=YOUR_API_KEY